Determination of serum anti-Mullerian hormone levels in a low-prognosis women treated in-vitro fertilization/intracytoplasmic sperm injection: A cohort study [PDF]
International Journal of Reproductive BioMedicine, 2022 Background: Outcome prediction of participants treated with in-vitro fertilization or intracytoplasmic sperm injection (IVF/ICSI) using anti-Mullerian hormone (AMH) concentration has been widely used.
Ferdy Royland Marpaung +4 more
doaj +3 more sources
Cumulative live birth rate in mild versus conventional stimulation in progestin-primed ovarian stimulation protocols for individuals with low prognosis [PDF]
Frontiers in Endocrinology, 2023 ObjectiveThe purpose of this study was to evaluate the cumulative live birth rate (CLBR) of mild stimulation and conventional stimulation for the low-prognosis population undergoing PPOS protocols.MethodsThis was a retrospective cohort study. We included
Junwei Zhang +4 more
doaj +2 more sources
Comparison of the Cumulative Live Birth Rates of Progestin-Primed Ovarian Stimulation and Flexible GnRH Antagonist Protocols in Patients With Low Prognosis [PDF]
Frontiers in Endocrinology, 2021 ObjectiveTo compare the cumulative live birth rate (CLBR) of the progestin-primed ovarian stimulation (PPOS) protocol with that of the flexible GnRH antagonist protocol in patients with poor prognosis diagnosed per the POSEIDON criteria.MethodsThis was a
Mingze Du +6 more
doaj +2 more sources
Medium-sized follicle proportion on the trigger day may be associated with higher live birth rate in fresh embryo transfer cycles among low-prognosis patients: a retrospective cohort study [PDF]
Frontiers in EndocrinologyObjectiveTo investigate the association of medium-size follicle proportions (MFP) on the trigger day with the pregnancy outcomes in low prognosis patients undergoing GnRH antagonist protocol.Materials and methodsA total of 1084 oocyte-retrieval cycles ...
Huiqun Yin +6 more
doaj +2 more sources
Cumulative Live Birth Rates in Low Prognosis Patients According to the POSEIDON Criteria: An Analysis of 26,697 Cycles of in vitro Fertilization/Intracytoplasmic Sperm Injection [PDF]
Frontiers in Endocrinology, 2019 Objective: The POSEIDON criteria are used to stratify patients with low prognosis after assisted reproductive technology (ART) treatment. Since its introduction, there has been no large study about the prognosis of the POSEIDON population.
Yuan Li +21 more
doaj +2 more sources
Editorial: POSEIDON’s Stratification of ‘Low Prognosis’ Patients in ART: The WHY, the WHAT, and the HOW [PDF]
Frontiers in Endocrinology, 2021 Sandro C. Esteves +6 more
doaj +2 more sources
Defining Low Prognosis Patients Undergoing Assisted Reproductive Technology: POSEIDON Criteria—The Why [PDF]
Frontiers in Endocrinology, 2018 Women with impaired ovarian reserve or poor ovarian response (POR) to exogenous gonadotropin stimulation present a challenge for reproductive specialists.
Sandro C. Esteves +8 more
doaj +2 more sources
Frontiers in Endocrinology, 2021 ObjectiveThe primary objective of the study was to assess traditional Chinese formula DKP supplementation in terms of efficacy and safety on reproductive outcomes of expected poor ovarian responder (POR, POSEIDON Group 4) undergoing in vitro ...
Jing-Yan Song +18 more
doaj +1 more source
Frontiers in Endocrinology, 2023 ObjectiveThe aim of this study was to describe the cumulative live birth rates (CLBRs) of young women with or without low prognosis according to the POSEIDON criteria after IVF/ICSI cycles and to investigate whether the diagnosis of low prognosis ...
Enqi Yan +8 more
doaj +1 more source
Improving Reporting of Clinical Studies Using the POSEIDON Criteria: POSORT Guidelines
Frontiers in Endocrinology, 2021 The POSEIDON (Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number) criteria were developed to help clinicians identify and classify low-prognosis patients undergoing assisted reproductive technology (ART) and provide guidance for ...
Sandro C. Esteves +16 more
doaj +1 more source